Phenylalanine (Phe) hydroxylase (PAH) deficiency leads to hyperphenylalaninemia (HPA) and tyrosine (Tyr) depletion. The study investigates Tyr homeostasis in patients with PAH deficiency and the effect of a slow-release amino acids therapy in phenylketonuria (PKU). Four complementary investigations were performed: (1) Tyr concentrations were monitored in 114 patients (10.6 ± 11.9 years) with PKU on...Read More
Frankfurt 5-7 November: Piam is attending CPhI Worldwide for the fourth consecutive year. The event brings together over 45,000 senior pharmaceutical professionals, and 2,500 exhibitors from 150 countries...Read More
Turin, 22-25 October 2019 PIAM takes part in the X National Congress SIMMESN (Italian Society for the Study of Inherited Metabolic Diseases and Newborn Screening), organizing a specific session, focused on slow-release protein substitutes of the Afenil line.Read More
PIAM, Italian leader in the dietary management of PKU and other IEM, is participating in SSIEM 2019, 2-6 September, Rotterdam. If you wish to contact us, please visit our stand E1.10Read More
